Abstract
Fourteen PEX genes are currently identified as genes responsible for peroxisome biogenesis disorders (PBDs). Patients with PBDs manifest as neurodegenerative symptoms such as neuronal migration defect and malformation of the cerebellum. To address molecular mechanisms underlying the pathogenesis of PBDs, mouse models for the PBDs have been generated by targeted disruption of Pex genes. Pathological phenotypes and metabolic abnormalities in Pex-knockout mice well resemble those of the patients with PBDs. The mice with tissue- or cell type-specific inactivation of Pex genes have also been established by using a Cre-loxP system. The genetically modified mice reveal that pathological phenotypes of PBDs are mediated by interorgan and intercellular communications. Despite the illustrations of detailed pathological phenotypes in the mutant mice, mechanistic insights into pathogenesis of PBDs are still underway. In this chapter, we overview the phenotypes of Pex-inactivated mice and the current understanding of the pathogenesis underlying PBDs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Abcd1:
-
ATP-binding cassette family D1
- ADAPS:
-
alkyl-dihydroxyacetone phosphate synthase
- BA:
-
bile acid
- BDNF:
-
brain-derived neurotrophic factor
- BM:
-
brain mutant
- Cnp:
-
2′,3′-cyclic nucleotide phosphodiesterase
- CNS:
-
central nervous system
- DHAPAT:
-
dihydroxyacetone phosphate acyltransferase
- DKO:
-
double knockout
- EGL:
-
external granule layer
- GSK3β:
-
glycogen synthase kinase 3 β
- IRD:
-
infantile Refsum disease
- IZ:
-
intermediate zone
- KO:
-
knockout
- MBP:
-
myelin basic protein
- MEF:
-
mouse embryonic fibroblast
- ML:
-
molecular layer
- NALD:
-
neonatal adrenoleukodystrophy
- PBD:
-
peroxisome biogenesis disorder
- PNS:
-
peripheral nervous systems
- PTS:
-
peroxisomal targeting signal
- RCDP:
-
rhizomelic chondrodysplasia punctata
- RING:
-
really interesting new gene
- TrkB:
-
tropomyosin-related kinase B
- vGlut2:
-
vesicular glutamate transporter 2
- VLCFA:
-
very-long-chain fatty acid
- VZ:
-
ventricular zone
- X-ALD:
-
X-linked adrenoleukodystrophy
- ZS:
-
Zellweger syndrome
- ZSD:
-
Zellweger spectrum disorder
References
Wanders RJA, Waterham HR (2006) Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 75:295–332
Weller S, Gould SJ, Valle D (2003) Peroxisome biogenesis disorders. Annu Rev Genomics Hum Genet 4:165–211
Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW (2006) Peroxisome biogenesis disorders. Biochim Biophys Acta Mol Cell Res 1763:1733–1748
Braverman N, Steel G, Obie C, Moser A, Moser H, Gould SJ et al (1997) Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet 15:369–376
Motley AM, Hettema EH, Hogenhout EM, Brites P, ten Asbroek ALMA, Wijburg FA et al (1997) Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat Genet 15:377–380
Purdue PE, Zhang JW, Skoneczny M, Lazarow PB (1997) Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat Genet 15:381–384
Barøy T, Koster J, Strømme P, Ebberink MS, Misceo D, Ferdinandusse S et al (2015) A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform. Hum Mol Genet 24:5845–5854
Waterham HR, Ebberink MS (2012) Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta Mol Basis Dis 1822:1430–1441
Fujiki Y, Okumoto K, Mukai S, Honsho M, Tamura S (2014) Peroxisome biogenesis in mammalian cells. Front Physiol 5:article 307
Fujiki Y (2016) Peroxisome biogenesis and human peroxisome-deficiency disorders. Proc Jpn Acad Ser B 92:463–477
Volpe JJ, Adams RD (1972) Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol 20:175–198
de León GA, Grover WD, Huff DS, Morinigo-Mestre G, Punnett HH, Kistenmacher ML (1977) Globoid cells, glial nodules, and peculiar fibrillary changes in the cerebro-hepato-renal syndrome of Zellweger. Ann Neurol 2:473–484
Evrard P, Caviness VSJ, Prats-Vinas J, Lyon G (1978) The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis bases upon cytoarchitectonic analysis. Acta Neuropathol 41:109–117
Gould SJ, Keller G-A, Hosken N, Wilkinson J, Subramani S (1989) A conserved tripeptide sorts proteins to peroxisomes. J Cell Biol 108:1657–1664
Miyazawa S, Osumi T, Hashimoto T, Ohno K, Miura S, Fujiki Y (1989) Peroxisome targeting signal of rat liver acyl-coenzyme A oxidase resides at the carboxy terminus. Mol Cell Biol 9:83–91
Miura S, Kasuya-Arai I, Mori H, Miyazawa S, Osumi T, Hashimoto T et al (1992) Carboxyl-terminal consensus Ser-Lys-Leu-related tripeptide of peroxisomal proteins functions in vitro as a minimal peroxisome-targeting signal. J Biol Chem 267:14405–14411
Osumi T, Tsukamoto T, Hata S, Yokota S, Miura S, Fujiki Y et al (1991) Amino-terminal presequence of the precursor of peroxisomal 3-ketoacyl-CoA thiolase is a cleavable signal peptide for peroxisomal targeting. Biochem Biophys Res Commun 181:947–954
Swinkels BW, Gould SJ, Bodnar AG, Rachubinski RA, Subramani S (1991) A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J 10:3255–3262
Tsukamoto T, Hata S, Yokota S, Miura S, Fujiki Y, Hijikata M et al (1994) Characterization of the signal peptide at the amino terminus of the rat peroxisomal 3-ketoacyl-CoA thiolase precursor. J Biol Chem 269:6001–6010
Fransen M, Brees C, Baumgart E, Vanhooren JC, Baes M, Mannaerts GP et al (1995) Identification and characterization of the putative human peroxisomal C-terminal targeting signal import receptor. J Biol Chem 270:7731–7736
Terlecky SR, Nuttley WM, McCollum D, Sock E, Subramani S (1995) The Pichia pastoris peroxisomal protein PAS8p is the receptor for the C-terminal tripeptide peroxisome targeting signal. EMBO J 14:3627–3634
van der Klei IJ, Hilbrands RE, Swaving GJ, Waterham HR, Vrieling EG, Titorenko VI et al (1995) The Hansenula polymorpha PER3 gene is essential for the import of PTS1 proteins into the peroxisomal matrix. J Biol Chem 270:17229–17236
Marzioch M, Erdmann R, Veenhuis M, Kunau W-H (1994) PAS7 encodes a novel yeast member of the WD-40 protein family essential for import of 3-oxoacy-CoA thiolase, a PTS2-containing protein, into peroxisomes. EMBO J 13:4908–4918
Mukai S, Ghaedi K, Fujiki Y (2002) Intracellular localization, function, and dysfunction of the peroxisome-targeting signal type 2 receptor, Pex7p, in mammalian cells. J Biol Chem 277:9548–9561
Zhang JW, Lazarow PB (1995) PEB1 (PAS7) in Saccharomyces cerevisiae encodes a hydrophilic, intra-peroxisomal protein that is a member of the WD receptor family and is essential for the import of thiolase into peroxisomes. J Cell Biol 129:65–80
Albertini M, Rehling P, Erdmann R, Girzalsky W, Kiel JAKW, Veenhuis M et al (1997) Pex14p, a peroxisomal membrane protein binding both receptors of the two PTS-dependent import pathways. Cell 89:83–92
Otera H, Harano T, Honsho M, Ghaedi K, Mukai S, Tanaka A et al (2000) The mammalian peroxin Pex5pL, the longer isoform of the mobile peroxisome targeting signal (PTS) type 1 transporter, translocates Pex7p-PTS2 protein complex into peroxisomes via its initial docking site, Pex14p. J Biol Chem 275:21703–21714
Shimizu N, Itoh R, Hirono Y, Otera H, Ghaedi K, Tateishi K et al (1999) The peroxin Pex14p: cDNA cloning by functional complementation on a Chinese hamster ovary cell mutant, characterization, and functional analysis. J Biol Chem 274:12593–12604
Bottger G, Barnett P, Klein ATJ, Kragt A, Tabak HF, Distel B (2000) Saccharomyces cerevisiae PTS1 receptor Pex5p interacts with the SH3 domain of the peroxisomal membrane protein Pex13p in an unconventional, non-PXXP-related manner. Mol Biol Cell 11:3963–3976
Gould SJ, Kalish JE, Morrell JC, Bjorkman J, Urquhart AJ, Crane DI (1996) Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTS1 receptor. J Cell Biol 135:85–95
Tsukamoto T, Miura S, Fujiki Y (1991) Restoration by a 35K membrane protein of peroxisome assembly in a peroxisome-deficient mammalian cell mutant. Nature 350:77–81
Chang C-C, Warren DS, Sacksteder KA, Gould SJ (1999) PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import. J Cell Biol 147:761–774
Okumoto K, Abe I, Fujiki Y (2000) Molecular anatomy of the peroxin Pex12p: RING finger domain is essential for Pex12p function and interacts with the peroxisome-targeting signal type 1-receptor Pex5p and a RING peroxin, Pex10p. J Biol Chem 275:25700–25710
Miyata N, Fujiki Y (2005) Shuttling mechanism of peroxisome targeting signal type 1 receptor Pex5: ATP-independent import and ATP-dependent export. Mol Cell Biol 25:10822–10832
Matsumoto N, Tamura S, Fujiki Y (2003) The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes. Nat Cell Biol 5:454–460
Fujiki Y, Matsuzono Y, Matsuzaki T, Fransen M (2006) Import of peroxisomal membrane proteins: the interplay of Pex3p- and Pex19p-mediated interactions. Biochim Biophys Acta Mol Cell Res 1763:1639–1646
Ma C, Agrawal G, Subramani S (2011) Peroxisome assembly: matrix and membrane protein biogenesis. J Cell Biol 193:7–16
Nuttall JM, Motley A, Hettema EH (2011) Peroxisome biogenesis: recent advances. Curr Opin Cell Biol 23:421–426
Rucktäschel R, Girzalsky W, Erdmann R (2011) Protein import machineries of peroxisomes. Biochim Biophys Acta 1808:892–900
Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M et al (1997) A mouse model for Zellweger syndrome. Nat Genet 17:49–57
Janssen A, Gressens P, Grabenbauer M, Baumgart E, Schad A, Vanhorebeek I et al (2003) Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues. J Neurosci 23:9732–9741
Faust PL, Hatten ME (1997) Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J Cell Biol 139:1293–1305
Faust PL, Su HM, Moser A, Moser HW (2001) The peroxisome deficient PEX2 Zellweger mouse: pathogenic and biochemical correlates of lipid dysfunction. J Mol Neurosci 16:289–297
Faust PL (2003) Abnormal cerebellar histogenesis in PEX2 Zellweger mice reflects multiple neuronal defects induced by peroxisome deficiency. J Comp Neurol 461:394–413
Faust PL, Banka D, Siriratsivawong R, Ng VG, Wikander TM (2005) Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain. J Inherit Metab Dis 28:369–383
Maxwell M, Bjorkman J, Nguyen T, Sharp P, Finnie J, Paterson C et al (2003) Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype. Mol Cell Biol 23:5947–5957
Hanson MG, Fregoso VL, Vrana JD, Tucker CL, Niswander LA (2014) Peripheral nervous system defects in a mouse model for peroxisomal biogenesis disorders. Dev Biol 395:84–95
Abe Y, Honsho M, Itoh R, Kawaguchi R, Fujitani M, Fujiwara K et al (2018) Peroxisome biogenesis deficiency attenuates the BDNF-TrkB pathway-mediated development of the cerebellum. Life Sci Alliance 1:e201800062
Brites P, Motley AM, Gressens P, Mooyer PAW, Ploegaert I, Everts V et al (2003) Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata. Hum Mol Genet 12:2255–2267
da Silva TF, Eira J, Lopes AT, Malheiro AR, Sousa V, Luoma A et al (2014) Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination. J Clin Invest 124:2560–2570
Brites P, Mooyer PAW, el Mrabet L, Waterham HR, Wanders RJA (2009) Plasmalogens participate in very-long-chain fatty acid-induced pathology. Brain 132:482–492
Li X, Baumgart E, Dong G-X, Morrell JC, Jimenez-Sanchez G, Valle D et al (2002) PEX11α is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation. Mol Cell Biol 22:8226–8240
Weng H, Ji X, Naito Y, Endo K, Ma X, Takahashi R et al (2013) Pex11α deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice. Am J Physiol Endocrinol Metab 304:E187–E196
Chen C, Wang H, Chen B, Chen D, Lu C, Li H et al (2019) Pex11a deficiency causes dyslipidaemia and obesity in mice. J Cell Mol Med 23:2020–2031
Li X, Baumgart E, Morrell JC, Jimenez-Sanchez G, Valle D, Gould SJ (2002) PEX11β deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol Cell Biol 22:4358–4365
Ahlemeyer B, Gottwald M, Baumgart-Vogt E (2012) Deletion of a single allele of the Pex11β gene is sufficient to cause oxidative stress, delayed differentiation and neuronal death in mouse brain. Dis Model Mech 5:125–140
Hiebler S, Masuda T, Hacia JG, Moser AB, Faust PL, Liu A et al (2014) The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder. Mol Genet Metab 111:522–532
Berendse K, Boek M, Gijbels M, Van der Wel NN, Klouwer FC, van den Bergh-Weerman MA et al (2019) Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder. Biochim Biophys Acta Mol Basis Dis 1865:2774–2787
Fujiki Y, Okumoto K, Kinoshita N, Ghaedi K (2006) Lessons from peroxisome-deficient Chinese hamster ovary (CHO) cell mutants. Biochim Biophys Acta Mol Cell Res 1763:1374–1381
Otera H, Fujiki Y (2012) Pex5p imports folded tetrameric catalase by interaction with Pex13p. Traffic 13:1364–1377
Kasarskis A, Manova K, Anderson KV (1998) A phenotype-based screen for embryonic lethal mutations in the mouse. Proc Natl Acad Sci USA 95:7485–7490
Shimozawa N, Tsukamoto T, Nagase T, Takemoto Y, Koyama N, Suzuki Y et al (2004) Identification of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene. Hum Mutat 23:552–558
Ohtaka-Maruyama C, Okado H (2015) Molecular pathways underlying projection neuron production and migration during cerebral cortical development. Front Neurosci 9:447
Berger J, Dorninger F, Forss-Petter S, Kunze M (2016) Peroxisomes in brain development and function. Biochem Biophys Acta 1863:934–955
Powers JM, Moser HW (1998) Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 8:101–120
Crane DI (2014) Revisiting the neuropathogenesis of Zellweger syndrome. Neurochem Int 69:1–8
Sotelo C, Dusart I (2009) Intrinsic versus extrinsic determinants during the development of Purkinje cell dendrites. Neuroscience 162:589–600
Fremeau RTJ, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ et al (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31:247–260
Ichikawa R, Miyazaki T, Kano M, Hashikawa T, Tatsumi H, Sakimura K et al (2002) Distal extension of climbing fiber territory and multiple innervation caused by aberrant wiring to adjacent spiny branchlets in cerebellar Purkinje cells lacking glutamate receptor δ2. J Neurosci 22:8487–8503
Sugihara I (2005) Microzonal projection and climbing fiber remodeling in single olivocerebellar axons of newborn rats at postnatal days 4–7. J Comp Neurol 487:93–106
Watanabe M, Kano M (2011) Climbing fiber synapse elimination in cerebellar Purkinje cells. Eur J Neurosci 34:1697–1710
Powers JM, Moser HW, Moser AB, Upshur JK, Bradford BF, Pai SG et al (1985) Fetal cerebrohepatorenal (Zellweger) syndrome: dysmorphic, radiologic, biochemical, and pathologic findings in four affected fetuses. Hum Pathol 16:610–620
Honsho M, Dorninger F, Abe Y, Setoyama D, Ohgi R, Uchiumi T et al (2019) Impaired plasmalogen synthesis dysregulates liver X receptor-dependent transcription in cerebellum. J Biochem 166:353–361
Hulshagen L, Krysko O, Bottelbergs A, Huyghe S, Klein R, Van Veldhoven PP et al (2008) Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration. J Neurosci 28:4015–4027
Bottelbergs A, Verheijden S, Van Veldhoven PP, Just W, Devos R, Baes M (2012) Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system. J Neuroinflammation 9:61
Russell DW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72:137–174
Keane MH, Overmars H, Wikander TM, Ferdinandusse S, Duran M, Wanders RJA et al (2007) Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice. Hepatology 45:982–997
Heymans HS, Oorthuys JW, Nelck G, Wanders RJ, Schutgens RB (1985) Rhizomelic chondrodysplasia punctata: another peroxisomal disorder. N Engl J Med 313:187–188
Agamanolis DP, Novak RW (1995) Rhizomelic chondrodysplasia punctata: report of a case with review of the literature and correlation with other peroxisomal disorders. Pediatr Pathol Lab Med 15:503–513
Ferdinandusse S, Ebberink MS, Vaz FM, Waterham HR, Wanders RJA (2016) The important role of biochemical and functional studies in the diagnostics of peroxisomal disorders. J Inherit Metab Dis 39:531–543
Waterham HR, Ferdinandusse S, Wanders RJA (2016) Human disorders of peroxisome metabolism and biogenesis. Biochem Biophys Acta 1863:922–933
Honsho M, Fujiki Y (2017) Plasmalogen homeostasis: regulation of plasmalogen biosynthesis and its physiological consequence in mammals. FEBS Lett 591:2720–2729
Wanders RJA, Schumacher H, Heikoop J, Schutgens RBH, Tager JM (1992) Human dihydroxyacetonephosphate acyltransferase deficiency: a new peroxisomal disorder. J Inherit Metab Dis 15:389–391
Wanders RJA, Dekker C, Hovarth VA, Schutgens RB, Tager JM, van Laer P et al (1994) Human alkyldihydroxyacetonephosphate synthase deficiency: a new peroxisomal disorder. J Inherit Metab Dis 17:315–318
Buchert R, Tawamie H, Smith C, Uebe S, Innes AM, Al Hallak B et al (2014) A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency. Am J Hum Genet 95:602–610
de Vet ECJM, van den Bosch H (2000) Alkyl-dihydroxyacetonephosphate synthase. Cell Biochem Biophys 32:117–121
Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ (1997) Identification of PAHX, a Refsum disease gene. Nat Genet 17:185–189
Jansen GA, Ofman R, Ferdinandusse S, Ijlst L, Muijsers AO, Skjeldal OH et al (1997) Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet 17:190–193
Wanders RJA, Smit W, Heymans HSA, Schutgens RBH, Barth PG, Schierbeek H et al (1987) Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zellweger) syndrome. Clin Chim Acta 166:45–56
Hoefler G, Hoefler S, Watkins PA, Chen WW, Moser A, Baldwin V et al (1988) Biochemical abnormalities in rhizomelic chondrodysplasia punctata. J Pediatr 112:726–733
Purdue PE, Skoneczny M, Yang X, Zhang JW, Lazarow PB (1999) Rhizomelic chondrodysplasia punctata, a peroxisomal biogenesis disorder caused by defects in Pex7p, a peroxisomal protein import receptor: a minireview. Neurochem Res 24:581–586
Wanders RJA, Denis S, Wouters F, Wirtz KWA, Seedorf U (1997) Sterol carrier protein X (SCPx) is a peroxisomal branched-chain b-ketothiolase specifically reacting with 3-oxo-pristanoyl-CoA: a new, unique role for SCPx in branched-chain fatty acid metabolism in peroxisomes. Biochem Biophys Res Commun 236:565–569
Moser HW, Moser AE, Singh I, O'Neill P (1984) Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Ann Neurol 16:628–641
Berger J, Gärtner J (2006) X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta 1763:1721–1732
Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW (2000) Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol 59:89–102
Moser HW (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485–1508
Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH et al (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50:829–843
Kobayashi T, Shinnoh N, Kondo A, Yamada T (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232:631–636
Lu J-F, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW et al (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 94:9366–9371
Lazarow PB, Fujiki Y (1985) Biogenesis of peroxisomes. Annu Rev Cell Biol 1:489–530
Koch A, Thiemann M, Grabenbauer M, Yoon Y, McNiven MA, Schrader M (2003) Dynamin-like protein 1 is involved in peroxisomal fission. J Biol Chem 278:8597–8605
Li X, Gould SJ (2003) The dynamin-like GTPase DLP1 is essential for peroxisome division and is recruited to peroxisomes in part by PEX11. J Biol Chem 278:17012–17020
Schrader M, Reuber BE, Morrell JC, Jimenez-Sanchez G, Obie C, Stroh TA et al (1998) Expression of PEX11β mediates peroxisome proliferation in the absence of extracellular stimuli. J Biol Chem 273:29607–29614
Abe I, Okumoto K, Tamura S, Fujiki Y (1998) Clofibrate-inducible, 28-kDa peroxisomal integral membrane protein is encoded by PEX11. FEBS Lett 431:468–472
Abe I, Fujiki Y (1998) cDNA cloning and characterization of a constitutively expressed isoform of the human peroxin Pex11p. Biochem Biophys Res Commun 252:529–533
Tanaka A, Okumoto K, Fujiki Y (2003) cDNA cloning and characterization of the third isoform of human peroxin Pex11p. Biochem Biophys Res Commun 300:819–823
Koch A, Schneider G, Lüers GH, Schrader M (2004) Peroxisome elongation and constriction but not fission can occur independently of dynamin-like protein 1. J Cell Sci 117:3995–4006
Itoyama A, Honsho M, Abe Y, Moser A, Yoshida Y, Fujiki Y (2012) Docosahexaenoic acid mediates peroxisomal elongation, a prerequisite for peroxisome division. J Cell Sci 125:589–602
Itoyama A, Michiyuki S, Honsho M, Yamamoto T, Moser A, Yoshida Y et al (2013) Mff functions with Pex11pβ and DLP1 in peroxisomal fission. Biol Open 2:998–1006
Yoshida Y, Niwa H, Honsho M, Itoyama A, Fujiki Y (2015) Pex11p mediates peroxisomal proliferation by promoting deformation of the lipid membrane. Biol Open 4:710–721
Ebberink MS, Koster J, Visser G, van Spronsen F, Stolte-Dijkstra I, Smit GPA et al (2012) A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11β gene. J Med Genet 49:307–313
Taylor RL, Handley MT, Waller S, Campbell C, Urquhart J, Meynert AM et al (2017) Novel PEX11B mutations extend the peroxisome biogenesis disorder 14B phenotypic spectrum and underscore congenital cataract as an early feature. Invest Ophthalmol Vis Sci 58:594–603
Tian Y, Zhang L, Li Y, Gao J, Yu H, Guo Y et al (2020) Variant analysis of PEX11B gene from a family with peroxisome biogenesis disorder 14B by whole exome sequencing. Mol Genet Genomic Med 8:e1042
Thoms S, Gärtner J (2012) First PEX11β patient extends spectrum of peroxisomal biogenesis disorder phenotypes. J Med Genet 49:314–316
Collins CS, Gould SJ (1999) Identification of a common PEX1 mutation in Zellweger syndrome. Hum Mutat 14:45–53
Steinberg S, Chen L, Wei L, Moser A, Moser H, Cutting G et al (2004) The PEX gene screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. Mol Genet Metab 83:252–263
Ebberink MS, Mooijer PAW, Gootjes J, Koster J, Wanders RJA, Waterham HR (2011) Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. Hum Mutat 32:59–69
Preuss N, Brosius U, Biermanns M, Muntau AC, Conzelmann E, Gartner J (2002) PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease. Pediatr Res 51:706–714
Walter C, Gootjes J, Mooijer PA, Portsteffen H, Klein C, Waterham HR et al (2001) Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. Am J Hum Genet 69:35–48
Tamura S, Matsumoto N, Imamura A, Shimozawa N, Suzuki Y, Kondo N et al (2001) Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction. Biochem J 357:417–426
Majewski J, Wang Z, Lopez I, Al Humaid S, Ren H, Racine J et al (2011) A new ocular phenotype associated with an unexpected but known systemic disorder and mutation: novel use of genomic diagnostics and exome sequencing. J Med Genet 48:593–596
Zhang R, Chen L, Jiralerspong S, Snowden A, Steinberg S, Braverman N (2010) Recovery of PEX1-Gly843Asp peroxisome dysfunction by small-molecule compounds. Proc Natl Acad Sci USA 107:5569–5574
Baes M, Dewerchin M, Janssen A, Collen D, Carmeliet P (2002) Generation of Pex5-loxP mice allowing the conditional elimination of peroxisomes. Genesis 32:177–178
Bjorkman J, Tonks I, Maxwell MA, Paterson C, Kay GF, Crane DI (2002) Conditional inactivation of the peroxisome biogenesis Pex13 gene by Cre-loxP excision. Genesis 32:179–180
Krysko O, Hulshagen L, Janssen A, Schütz G, Klein R, De Bruycker M et al (2007) Neocortical and cerebellar developmental abnormalities in conditions of selective elimination of peroxisomes from brain or from liver. J Neurosci Res 85:58–72
Müller CC, Nguyen TH, Ahlemeyer B, Meshram M, Santrampurwala N, Cao S et al (2011) PEX13 deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress. Dis Model Mech 4:104–119
Rahim RS, St John JA, Crane DI, Meedeniya ACB (2018) Impaired neurogenesis and associated gliosis in mouse brain with PEX13 deficiency. Mol Cell Neurosci 88:16–32
Rahim RS, Meedeniya AC, Crane DI (2014) Central serotonergic neuron deficiency in a mouse model of Zellweger syndrome. Neuroscience 274:229–241
Kassmann CM, Lappe-Siefke C, Baes M, Brügger B, Mildner A, Werner HB et al (2007) Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 39:969–976
Bottelbergs A, Verheijden S, Hulshagen L, Gutmann DH, Goebbels S, Nave K-A et al (2010) Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes. Glia 58:1532–1543
Kassmann CM, Quintes S, Rietdorf J, Mobius W, Sereda MW, Nientiedt T et al (2011) A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity. FEBS Lett 585:2205–2211
Streit WJ, Walter SA, Pennell NA (1999) Reactive microgliosis. Prog Neurobiol 57:563–581
Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305:217
Kellendonk C, Opherk C, Anlag K, Schütz G, Tronche F (2000) Hepatocyte-specific expression of Cre recombinase. Genesis 26:151–153
Tronche F, Opherk C, Moriggl R, Kellendonk C, Reimann A, Schwake L et al (2004) Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev 18:492–497
Dirkx R, Vanhorebeek I, Martens K, Schad A, Grabenbauer M, Fahimi D et al (2005) Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities. Hepatology 41:868–878
Gravel M, Di Polo A, Valera PB, Braun PE (1998) Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J Neurosci Res 53:393–404
Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE et al (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366–374
Kleinecke S, Richert S, de Hoz L, Brugger B, Kungl T, Asadollahi E et al (2017) Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy. elife 6:e23332
Bajenaru ML, Zhu Y, Hedrick NM, Donahoe J, Parada LF, Gutmann DH (2002) Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Biol Cell 22:5100–5113
Goebbels S, Bormuth I, Bode U, Hermanson O, Schwab MH, Nave K-A (2006) Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice. Genesis 44:611–621
Kong J, Ji Y, Jeon YG, Han JS, Han KH, Lee JH et al (2020) Spatiotemporal contact between peroxisomes and lipid droplets regulates fasting-induced lipolysis via PEX5. Nat Commun 11:578
Park H, He A, Tan M, Johnson JM, Dean JM, Pietka TA et al (2019) Peroxisome-derived lipids regulate adipose thermogenesis by mediating cold-induced mitochondrial fission. J Clin Invest 129:694–711
Martens K, Bottelbergs A, Peeters A, Jacobs F, Espeel M, Carmeliet P et al (2012) Peroxisome deficient aP2-Pex5 knockout mice display impaired white adipocyte and muscle function concomitant with reduced adrenergic tone. Mol Genet Metab 107:735–747
Brauns AK, Heine M, Todter K, Baumgart-Vogt E, Luers GH, Schumacher U (2019) A defect in the peroxisomal biogenesis in germ cells induces a spermatogenic arrest at the round spermatid stage in mice. Sci Rep 9:9553
Baboota RK, Shinde AB, Lemaire K, Fransen M, Vinckier S, Van Veldhoven PP et al (2019) Functional peroxisomes are required for β-cell integrity in mice. Mol Metab 22:71–83
Minichiello L, Klein R (1996) TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons. Genes Dev 10:2849–2858
Schwartz PM, Borghesani PR, Levy RL, Pomeroy SL, Segal RA (1997) Abnormal cerebellar development and foliation in BDNF−/− mice reveals a role for neurotrophins in CNS patterning. Neuron 19:269–281
Carter AR, Chen C, Schwartz PM, Segal RA (2002) Brain-derived neurotrophic factor modulates cerebellar plasticity and synaptic ultrastructure. J Neurosci 22:1316–1327
Zhou P, Porcionatto M, Pilapil M, Chen Y, Choi Y, Tolias KF et al (2007) Polarized signaling endosomes coordinate BDNF-induced chemotaxis of cerebellar precursors. Neuron 55:53–68
Aubourg P, Scotto J, Rocchiccioli F, Feldmann-Pautrat D, Robain O (1986) Neonatal adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 49:77–86
Torvik A, Torp S, Kase BF, Ek J, Skjeldal O, Stokke O (1988) Infantile Refsum’s disease: a generalized peroxisomal disorder. Case report with postmortem examination. J Neurol Sci 85:39–53
Chow CW, Poulos A, Fellenberg AJ, Christodoulou J, Danks DM (1992) Autopsy findings in two siblings with infantile Refsum disease. Acta Neuropathol 83:190–195
Alkan A, Kutlu R, Yakinci C, Sigirci A, Aslan M, Sarac K (2003) Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings. Magn Reson Imaging 21:77–80
Bams-Mengerink AM, Majoie CB, Duran M, Wanders RJ, Van Hove J, Scheurer CD et al (2006) MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata. Neurology 66:798–803
Rodemer C, Thai TP, Brugger B, Kaercher T, Werner H, Nave KA et al (2003) Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum Mol Genet 12:1881–1895
Teigler A, Komljenovic D, Draguhn A, Gorgas K, Just WW (2009) Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum. Hum Mol Genet 18:1897–1908
Honsho M, Abe Y, Fujiki Y (2015) Dysregulation of plasmalogen homeostasis impairs cholesterol biosynthesis. J Biol Chem 290:28822–28833
Van Veldhoven PP, Baes M (2013) Peroxisome deficient invertebrate and vertebrate animal models. Front Physiol 4:335
Thieringer H, Moellers B, Dodt G, Kunau W-H, Driscoll M (2003) Modeling human peroxisome biogenesis disorders in the nematode Caenorhabditis elegans. J Cell Sci 116:1797–1804
Curran SP, Ruvkun G (2007) Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet 3:e56
Zhou B, Yang L, Li S, Huang J, Chen H, Hou L et al (2012) Midlife gene expressions identify modulators of aging through dietary interventions. Proc Natl Acad Sci USA 109:E1201–E1209
Koizumi K, Higashida H, Yoo S, Islam MS, Ivanov AI, Guo V et al (2007) RNA interference screen to identify genes required for Drosophila embryonic nervous system development. Proc Natl Acad Sci USA 104:5626–5631
Mast FD, Li J, Virk MK, Hughes SC, Simmonds AJ, Rachubinski RA (2011) A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders. Dis Model Mech 4:659–672
Di Cara F, Rachubinski RA, Simmonds AJ (2019) Distinct roles for peroxisomal targeting signal receptors Pex5 and Pex7 in Drosophila. Genetics 211:141–149
Setchell KD, Bragetti P, Zimmer-Nechemias L, Daugherty C, Pelli MA, Vaccaro R et al (1992) Oral bile acid treatment and the patient with Zellweger syndrome. Hepatology 15:198–207
Maeda K, Kimura A, Yamato Y, Nittono H, Takei H, Sato T et al (2002) Oral bile acid treatment in two Japanese patients with Zellweger syndrome. J Pediatr Gastroenterol Nutr 35:227–230
Demaret T, Varma S, Stephenne X, Smets F, Scheers I, Wanders R et al (2018) Living-donor liver transplantation for mild Zellweger spectrum disorder: up to 17 years follow-up. Pediatr Transplant 22:e13112
Acknowledgments
We apologize to the colleagues in this field for not citing all their work due to space limitations. This work was supported in part by the Grants-in-Aid for Scientific Research: JP17K15621 and JP19K07386 (to Y.A.), JP19K06567 (to S.T.), JP17K07337 (to M.H.), JP24247038, JP25112518, JP25116717, JP 26116007, JP15K14511, JP15K21743, and JP117H03675 (to Y.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants from the Takeda Science Foundation and the Naito Foundation to Y.F.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Abe, Y., Tamura, S., Honsho, M., Fujiki, Y. (2020). A Mouse Model System to Study Peroxisomal Roles in Neurodegeneration of Peroxisome Biogenesis Disorders. In: Lizard, G. (eds) Peroxisome Biology: Experimental Models, Peroxisomal Disorders and Neurological Diseases. Advances in Experimental Medicine and Biology, vol 1299. Springer, Cham. https://doi.org/10.1007/978-3-030-60204-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-60204-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-60203-1
Online ISBN: 978-3-030-60204-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)